Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from Small Business Concerns (SBCs) to pursue translational activities and limited-size clinical studies to advance the development of therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems.

Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities leading to submission of an Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) or Institutional Review Board (IRB) application for a Non-Significant Risk (NSR) study. The clinical study is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. This FOA is a milestone-driven cooperative agreement program and will involve participation of NIH program staff in negotiating the final project plan before award and monitoring of research progress.

Participants in Blueprint MedTech receive funding for all activities to be conducted in their own laboratories. In addition, applicants will collaborate with NIH-funded consultants to receive assistance with specialty areas including regulatory, reimbursement, intellectual property, commercialization, and strategic partnerships. Participants can also augment their project with NIH contract research organizations (CROs) that specialize in large animal testing, sterilization testing, biocompatibility assessment, manufacturing, and medical monitoring.

SBCs developing their own devices or that already have established collaborations with device manufacturers are welcome to apply directly to this FOA or any of the companion opportunities. For more information see BP MedTech website: https://neuroscienceblueprint.nih.gov/neurotherapeutics/blueprint-medtech

 

Companion FOAs:

 

PAR-21-315UG3UH3 Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)

PAR-21-314 ,U54 Blueprint MedTech: Incubator Hubs (U54 Clinical Trial Not Allowed)

Deadlines:

  • Letter of Intent Due Date(s): 60 days prior to the application due date.

  • Application Due Dates: Oct 20, 2021; Feb 18, 2022; Jun 20, 2022; Oct 18, 2022; Feb 21, 2023; Jun 19, 2023; Oct 18, 2023; Feb 20, 2024; Jun 20, 2024

PAR-21-282 Expiration Date June 21, 2024

Agency Website

Eligibility Requirements

Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.

Funding Type

Grant

Eligibility

Faculty

Category

Engineering and Physical Sciences
Medical
Medical - Clinical Science
Medical - Translational

External Deadline

October 18, 2022